About Medioint Lifescience Private Limited
Data last updated:
Medioint Lifescience Private Limited is a private limited company based in Dhar, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2020PTC052158. Its GSTIN is 23AANCM6521G1ZJ (Madhya Pradesh).
The company has an authorised share capital of ₹2.75 Cr and a paid-up capital of ₹2.63 Cr. It is led by directors including Mukesh Kumar Joshi and Arvindkumar Dillu Saroj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dhar, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.68 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹4.24 Lakh (net margin 0.4%) and EBITDA of ₹1.51 Cr (EBITDA margin 14.1%).
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.86 Cr on record. Court records list 24 cases involving the company, including 4 filed by the company and 20 filed against it; 19 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mediointlifescience.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 260 – A, Sector – III Industrial Growth Center, Dhar, Madhya Pradesh, India – 454775
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medioint Lifescience Private Limited
The main business activity of Medioint Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medioint Lifescience Private Limited FY 2025 filings available
Medioint Lifescience Private Limited reported revenue of ₹10.68 Cr (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medioint Lifescience Private Limited
Revenue fell 1% in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medioint Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.51 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.24 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medioint Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medioint Lifescience are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medioint Lifescience Private Limited
Medioint Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Embellish Pharma Tech Private Limited | •••• | •••• | •••• | •••• | - | Roorkee, Uttarakhand, India |
| Elite Pharma Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Biogenomics Limited | •••• | •••• | •••• | •••• | 141 | Pondicherry, India |
| Arck Life Care Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Avenza Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Vadodara, Gujarat, India |
| Medioint Lifescience Private Limited this company | •••• | •••• | •••• | •••• | - | Dhar, Madhya Pradesh, India |
| Ashoka Pharmachem Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
| Pharm Products Private Limited | •••• | •••• | •••• | •••• | - | Thanjavur, Tamil Nadu, India |
| Skyogen Healthcare Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Renovate Biologicals Private Limited | •••• | •••• | •••• | •••• | 25 | Mahabubnagar, Telangana, India |
| Vista Pharmaceuticals Ltd. Listed | •••• | •••• | •••• | •••• | 24 | Telangana, India |
Peers are the five companies nearest above and the five nearest below Medioint Lifescience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Medioint Lifescience Private Limited
Medioint Lifescience Private Limited is audited by M. K. Shah & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M. K. Shah & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medioint Lifescience Private Limited
Medioint Lifescience has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Joshi | Director | 03 Aug 2020 | 6 Years 2 Months | Current |
| Arvindkumar Dillu Saroj | Director | 03 Aug 2020 | 6 Years 2 Months | Current |
| Satish Ramrao Pawar | Director | 03 Aug 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Medioint Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medioint Lifescience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2025 | Sidbi | ₹2.8 Cr | Open |
| 11 Aug 2023 | Others | ₹30 Lakh | Open |
| 24 Feb 2023 | Others | ₹1.76 Cr | Open |
| 29 Oct 2021 | Others | ₹1.5 Cr | Open |
| 27 Oct 2021 | Others | ₹3.5 Cr | Open |
Total charge records: 5 View all charges
Legal Cases of Medioint Lifescience Private Limited
Medioint Lifescience Private Limited has 24 court cases on record: 4 filed by Medioint Lifescience, 20 filed against it. 19 cases are pending and 5 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 20 | 19 |
| NCLAT | 4 | 0 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (RCS B) | Filed against the company by Sarthak Pet Industries (India) Private Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Konark Herbals and Healthcare Private Limited | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by Uflex Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Salvi Chemical Industries Limited | Pending |
| District court, Kamrup, Assam | Cheque dishonour complaint | Filed against the company by Abdos Lamitubes Private Limited | Pending |
Full case history
All 24 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Medioint Lifescience Private Limited
Medioint Lifescience Private Limited has a workforce of 17 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medioint Lifescience Private Limited
Medioint Lifescience Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Attaullah Tabarak Ansari ceased to be Director on 08 May 2025.
Credit Ratings, Litigation & Regulatory Alerts for Medioint Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medioint Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medioint Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medioint Lifescience Private Limited
Medioint Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AANCM6521G1ZJ | Madhya Pradesh | Active | 09 Sep 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medioint Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medioint Lifescience Private Limited
Medioint Lifescience is an active private limited company based in Dhar, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 August 2020 (6+ years old) and is registered under CIN U24230MP2020PTC052158.
Medioint Lifescience reported revenue of ₹10.68 Cr for FY 2025 (down 1% YoY).
Medioint Lifescience has 3 current directors:
- Mukesh Kumar Joshi - Director
- Arvindkumar Dillu Saroj - Director
- Satish Ramrao Pawar - Director
Medioint Lifescience reported a net profit of ₹4.24 Lakh (net margin 0.4%) and EBITDA of ₹1.51 Cr (EBITDA margin 14.1%) for FY 2025, as per its filed financial statements.
The GSTIN of Medioint Lifescience is 23AANCM6521G1ZJ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Medioint Lifescience is U24230MP2020PTC052158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medioint Lifescience has 24 court cases on record: 4 filed by the company and 20 filed against it. 19 are pending. Most are in the district courts.
Medioint Lifescience was incorporated on 03 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Medioint Lifescience by revenue are Embellish Pharma Tech Private Limited, Elite Pharma Private Limited, Biogenomics Limited, Arck Life Care Private Limited, Avenza Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Attaullah Tabarak Ansari ceased to be Director on 08 May 2025. Arvindkumar Dillu Saroj was appointed as Director on 03 Aug 2020. Mukesh Kumar Joshi was appointed as Director on 03 Aug 2020. Medioint Lifescience has 4 board changes on record in total.
Medioint Lifescience can be reached through the website mediointlifescience.com. Its registered office is in Dhar, Madhya Pradesh, India.